Tripping Goes High-Tech, Field Trip Partners with WHOOP

Psychedelics meet tech with Field Trip and WHOOP

Psychedelics development company, Field Trip, has announced a revolutionary partnership with wearable technology company WHOOP. WHOOP currently produces a lightweight watch that encourages better sleep. It monitors your heart rate, syncs with mobile devices, and is waterproof. The company claims you can even swim in the ocean while wearing their watch. 

The two companies announced that they will be using WHOOP’s Strap 3.0 to measure the biometric effects of ketamine-assisted therapies produced by Field Trip. Note: whether or not the therapeutic watches are waterproof are unclear; it’s likely they are not.

Field Trip will conduct an observational study to determine whether or not the company’s ketamine-assisted therapies have any impact on physical health. Ketamine-assisted therapies have been studied and shown to have significant improvements in aiding many mental health conditions, such as anxiety, PTSD, and depression. This study published in JAMA Psychiatry explores the strategic use of psilocybin to combat depression. The results suggest that psilocybin in combination with therapy may be effective for depression, “thus extending the results of previous studies of this intervention in patients with cancer and depression and of a nonrandomized study in patients with treatment-resistant depression.” The study required participants to be between the ages of 21-75 years, with an MDD diagnosis, not currently taking antidepressants, no history of psychosis or serious suicide attempts/hospitalizations. 

Field Trip’s findings

“The clinical results from our first three centers in Toronto, New York and Los Angeles, as determined by validated mental health measures, have been extremely positive. We have noted a significant reduction in depressive symptoms from severe or moderately severe to mild or non-existent, along with reduction in anxiety and trauma related symptoms,” said Dr. Ryan Yermus, Field Trip’s Chief Clinical Officer. “Through this partnership with WHOOP and the observational study we will be conducting, we expect to find that these improvements in mental health correlate strongly to improvements in a person’s biometrics as well.”

Field Trip focuses on veterans 

Field Trip’s Basecamp program will be the initial focus of the study. Basecamp is a program designed specifically for veterans and people in high-intensity careers such as front line medical workers, police officers, and firefighters. Military veterans experienced post-traumatic stress disorder (PTSD) at much higher rates than the general population, which ketamine-assisted therapies may be able to help with under the correct pretenses. 

“In their continual search for a persistent, unfair advantage on the battlefield, Special Operations veterans are highly attuned to their physical and mental performance and well-being,” said Adam Wright, Director of Field Trip Basecamp. “Deploying WHOOP as part of their treatment program is consistent with this natural disposition of veterans. We not only expect veterans to be eager to participate in a study that will help future veterans, we also anticipate they will optimize their performance and experience additional health improvements through actionable insights from WHOOP across sleep, recovery, and strain.”

Final thoughts 

Kristen Holmes, Vice President of Performance Science at WHOOP, commented: “Through our initial work with SEAL Future Foundation, we were able to show that psilocybin and ayahuasca therapies had profoundly positive effects on the physiology of veteran SEALs. With this program at Field Trip, which is offering legal treatment with psychedelic therapies across North America and Europe, we hope to be part of the healing of a much larger group of people, and further show that 24/7 health monitoring by WHOOP technology can help people take control of their overall well-being when used in association with new mental and emotional health therapies.”

“At Field Trip, our mission is to bring the world to life through psychedelics and psychedelic-enhanced therapies,” said Ronan Levy, Field Trip’s Executive Chairman. “Through this partnership with WHOOP, we hope to demonstrate that our work not only changes the mental and emotional well-being of people, it also tangible and meaningfully gets expressed through their physical well-being as well.”

Kaitlin Domangue

Kaitlin DomangueKaitlin Domangue

Kaitlin is a 23-year-old wife and mom to three children. She is a financial reporter for the Green Market Report and a freelance writer for other businesses in the cannabis space.


Leave a Reply

Your email address will not be published. Required fields are marked *


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 days

The Daily Hit: November 25, 2020

@GreenMarketRpt – 2 days

$PLNHF ⁦@Planet13lv⁩ Revenue Rises 36% To $22 Million, Turns A Profit

@GreenMarketRpt – 2 days

$VREOF ⁦@VireoHealth⁩ Revenue Rises 67%, Turns Profitable

Back to Top

You have Successfully Subscribed!